Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Jagerovic

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Mini Reviews in Medicinal Chemistry|October 8, 2003
Cannabinoids and neuropathic painP Goya, N Jagerovic, L Hernandez-Folgado, et al.
Journal of Photochemistry and Photobiology. B, Biology|April 1, 1995
Photosensitization with derivatives of chlorin p6D Kessel, K Woodburn, C J Gomer, et al.
Journal of the American Chemical Society|August 9, 2001
A solid-state NMR, X-ray diffraction, and ab initio computational study of hydrogen-bond structure and dynamics of pyrazole-4-carboxylic acid chainsC Foces-Foces, A Echevarría, N Jagerovic, et al.
Pharmacological Research|March 26, 2016
Biological characterization of PM226, a chromenoisoxazole, as a selective CB2 receptor agonist with neuroprotective profileM Gómez-Cañas, P Morales, L García-Toscano, et al.
Neuropharmacology|July 1, 2026
PM289, a synthetic CB2 in vitro receptor agonist, modulates morphine-induced antinociceptive effect and withdrawal syndrome in an animal model of osteoarthritic painM M Garcia, N Paniagua, P Morales, et al.
Pharmacological Research|April 24, 2017
Corrigendum to "Biological characterization of PM226, a chromenoisoxazole, as a selective CB<sub>2</sub> receptor agonist with neuroprotective profile" [Pharmacol. Res. 110 (August 2016) (2016) 205-215]M Gómez-Cañas, P Morales, L García-Toscano, et al.
Journal of Neuroendocrinology|May 9, 2008
Central versus peripheral antagonism of cannabinoid CB1 receptor in obesity: effects of LH-21, a peripherally acting neutral cannabinoid receptor antagonist, in Zucker ratsF J Pavón, A Serrano, V Pérez-Valero, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Mini Reviews in Medicinal Chemistry|October 8, 2003
Cannabinoids and neuropathic painP Goya, N Jagerovic, L Hernandez-Folgado, et al.
Journal of Photochemistry and Photobiology. B, Biology|April 1, 1995
Photosensitization with derivatives of chlorin p6D Kessel, K Woodburn, C J Gomer, et al.
Journal of the American Chemical Society|August 9, 2001
A solid-state NMR, X-ray diffraction, and ab initio computational study of hydrogen-bond structure and dynamics of pyrazole-4-carboxylic acid chainsC Foces-Foces, A Echevarría, N Jagerovic, et al.
Pharmacological Research|March 26, 2016
Biological characterization of PM226, a chromenoisoxazole, as a selective CB2 receptor agonist with neuroprotective profileM Gómez-Cañas, P Morales, L García-Toscano, et al.
Neuropharmacology|July 1, 2026
PM289, a synthetic CB2 in vitro receptor agonist, modulates morphine-induced antinociceptive effect and withdrawal syndrome in an animal model of osteoarthritic painM M Garcia, N Paniagua, P Morales, et al.
Pharmacological Research|April 24, 2017
Corrigendum to "Biological characterization of PM226, a chromenoisoxazole, as a selective CB<sub>2</sub> receptor agonist with neuroprotective profile" [Pharmacol. Res. 110 (August 2016) (2016) 205-215]M Gómez-Cañas, P Morales, L García-Toscano, et al.
Journal of Neuroendocrinology|May 9, 2008
Central versus peripheral antagonism of cannabinoid CB1 receptor in obesity: effects of LH-21, a peripherally acting neutral cannabinoid receptor antagonist, in Zucker ratsF J Pavón, A Serrano, V Pérez-Valero, et al.
Pageof 1